- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02850120
Complications of Mesh Procedures for Stress Urinary Incontinence (SUI-mesh)
Complications Following Tension-free Vaginal Tape (TVT), Trans-obturator Tape (TOT) and Suprapubic Sling (SS) Procedures for Stress Urinary Incontinence: 8-year Retrospective Cohort Study Using Hospital Episodes Statistics Data
Complications from mesh procedures (i.e. insertion of tension-free vaginal tapes (TVT), trans-obturator tapes (TOT) and suprapubic slings (SS)) used during surgical treatment of stress urinary incontinence have caused major concern around the world.
The investigators aim to conduct a retrospective cohort study using administrative inpatient data from the Hospital Episode Statistics (HES) database to determine the complications of all first-time surgical mesh procedures in the treatment of stress urinary incontinence (SUI) in women treated in a National Health Service (NHS) hospital in England who were discharged from hospital between 1st April 2007 and 31st March 2015.
The primary outcome measure is the number and types of complications (occurring peri-procedurally, within 30 days of the mesh procedure and those occurring during follow-up). Additional outcomes recorded include: the numbers and types of mesh procedures, including those with potentially confounding concomitant procedures.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women with an Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures 4th revision (OPCS-4) procedure code for an introduction of a Tension-free Vaginal Tape (TVT: M53.3), Trans-Obturator Tape (TOT: M53.6) or Supra-pubic Sling (SS: M52.1) surgical mesh procedure recorded in any of the 24 procedure fields captured in HES, and a recorded diagnosis of stress urinary incontinence based on International Classification of Diseases 10th revision (ICD-10) diagnoses: N39.3, N39.4, R32: T83.1, T83.4, T83.5, T83.6, T83.6, T83.8, T83.9, Z46.6, in any of the 20 diagnosis fields captured in HES.
Exclusion Criteria:
- Duplicate episode of care (exact match on patient identifier; admission date and method; discharge date, destination and method; hospital, gender, age, all procedure codes and all diagnostic codes)
- Male gender
- Missing age
- Aged less than 18 years
- Invalid or missing admission method
- Missing admission date
- Patients with recorded episodes of care in HES which appear after a reported date of death.
- Concomitant mesh surgery for pelvic organ prolapse surgery, or surgical mesh repair, removal, renewal or subsequent mesh insertion.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Unconfounded
All hospital admissions including Tension-free Vaginal Tape (TVT), Trans-obturator tape (TOT) or suprapubic sling (SS) procedures with:
|
Surgical insertion of Tension-free vaginal tape (TVT) polypropylene mesh in the treatment of stress urinary incontinence.
Surgical insertion of Trans-obturator tape (TOT) polypropylene mesh in the treatment of stress urinary incontinence.
Surgical insertion of Suprapubic sling (SS) polypropylene mesh in the treatment of stress urinary incontinence.
|
|
Confounded
All hospital admissions for insertion of Tension-free Vaginal Tape (TVT), Trans-obturator tape (TOT) or suprapubic sling (SS) procedures with concomitant procedures likely to affect outcomes.
|
Surgical insertion of Tension-free vaginal tape (TVT) polypropylene mesh in the treatment of stress urinary incontinence.
Surgical insertion of Trans-obturator tape (TOT) polypropylene mesh in the treatment of stress urinary incontinence.
Surgical insertion of Suprapubic sling (SS) polypropylene mesh in the treatment of stress urinary incontinence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Long-term complications
Time Frame: Longitudinal analysis of all episodes of care available in HES (up to 96 months)
|
Readmission for further mesh surgery or for symptoms indicating complication
|
Longitudinal analysis of all episodes of care available in HES (up to 96 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Type of mesh used
Time Frame: Longitudinal analysis of all episodes of care available in HES (up to 96 months)
|
Frequency of each type of mesh procedure (TVT, TOT, SS) used over time
|
Longitudinal analysis of all episodes of care available in HES (up to 96 months)
|
|
Frequency of treatment-related adverse events during initial hospital stay for mesh insertion procedure
Time Frame: During hospital admission when surgical mesh was inserted (length of hospital stay can vary between patients from 0-100 days)
|
Frequency of complication
|
During hospital admission when surgical mesh was inserted (length of hospital stay can vary between patients from 0-100 days)
|
|
Nature of treatment-related adverse events as determined by clinical coding practice of ICD-10 codes (Aylin et al. BMJ. 2004)
Time Frame: During hospital admission when surgical mesh was inserted (length of hospital stay can vary between patients from 0-100 days)
|
Nature of complication
|
During hospital admission when surgical mesh was inserted (length of hospital stay can vary between patients from 0-100 days)
|
|
Frequency of 30-day complications
Time Frame: Occurring within 30 days of surgical mesh insertion procedure
|
Frequency and nature of complication
|
Occurring within 30 days of surgical mesh insertion procedure
|
|
Nature of treatment-related adverse events occurring within 30 days of mesh procedure as determined by clinical coding practice of ICD-10 codes (Aylin et al. BMJ. 2004)
Time Frame: Occurring within 30 days of surgical mesh insertion procedure
|
Nature of complication
|
Occurring within 30 days of surgical mesh insertion procedure
|
Collaborators and Investigators
Investigators
- Principal Investigator: Andrew Sims, PhD, Newcastle upon Tyne Hospitals NHS Foundation Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RX029_MESH_SUI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
ScitonCompletedUrinary Incontinence | Stress Urinary Incontinence | Urge IncontinenceUnited States
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
University of ZurichCompletedStress Urinary Incontinence | Urge Urinary Incontinence
-
GT Urological, LLCCompletedMale Stress Urinary IncontinenceAustralia, Czechia, New Zealand
-
Zekai Tahir Burak Women's Health Research and Education...CompletedFemale Urinary Stress IncontinenceTurkey
Clinical Trials on Tension-free vaginal tape (TVT)
-
Austrian Urogynecology Working Group (AUWG)Completed
-
The Cleveland ClinicDuke University; Medstar Health Research Institute; Women and Infants Hospital... and other collaboratorsCompletedStress Urinary IncontinenceUnited States
-
Ain Shams UniversityCompleted
-
Medprin Regenerative Medical Technologies Co.,...Unknown
-
HaEmek Medical Center, IsraelUnknownPelvic Organ ProlapseIsrael
-
Norwegian University of Science and TechnologyOslo University Hospital; St. Olavs Hospital; Alesund HospitalCompletedUrinary Incontinence,StressNorway
-
Ethicon, Inc.CompletedStress Urinary IncontinenceKorea, Republic of, United States, Canada, France, Germany, Singapore, United Kingdom
-
Zeynep Kamil Maternity and Pediatric Research and...CompletedPelvic Floor Disorders | Stress Urinary Incontinence in WomenTurkey (Türkiye)
-
Ain Shams Maternity HospitalCompletedMed: Urinary Incontinence (Stress, Urge, Mixed)
-
Ain Shams UniversityCompletedStress Urinary IncontinenceEgypt